When is it time to get the joint checked?

When is an ordinary visit worth it?

Make an appointment once the ache interrupts sleep, walking, dressing, or exercise. Expect questions about the first sore day and the motions that bother you now. Bring your medicine list, and tell the clinician which care you've tried, when the soreness began, how it has changed, and which motions now bother you during ordinary tasks.

The exam may include checks of movement, swelling, and strength. The clinician might review an x-ray, ultrasound, or another scan of your joint. You may need a new scan, or the office might ask for an older one.

The key comes first: the exam needs to explain why your joint hurts.

What can make a procedure riskier?

Tell the clinician if you have diabetes, since steroid can briefly raise blood sugar. Don't leave out blood thinners, bleeding trouble, an active infection, or an illness that weakens your body's defenses. Those facts can change whether a procedure is safe.

Don't stop a prescribed blood thinner based on general web advice. If replacement surgery is planned, give the surgeon every recent procedure date. A steroid shot during the three months before replacement may raise the chance of infection around the new joint.

Your health and the timing both count.

What isn't normal afterward?

Some soreness after a procedure can happen. Your take-home directions need to say when it ought to ease. Don't stay home with growing heat, more swelling, fever, or a sick feeling. New weakness or no ability to stand on the joint also needs prompt care. If your hip hurts much more after steroid, have it checked again.

Normal soreness settles. Feeling worse calls for an exam.

Sources

1. The 2019 ACR/Arthritis Foundation OA guideline makes a STRONG recommendation for intra-articular glucocorticoid injection in knee OA, alongside strong recommendations for exercise, weight loss, self-management, tai chi, cane use, bracing and NSAIDs; intra-articular steroid injection for HAND OA is only conditionally recommended.

   Kolasinski SL, et al. — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.. Arthritis Rheumatol, 2020. DOI: 10.1002/art.41142.

2. The 2015 Cochrane review of 27 trials (1,767 participants) found intra-articular corticosteroid better than sham for knee OA pain (SMD -0.40, 95% CI -0.58 to -0.22; NNTB 8), but the benefit decayed with time: moderate at 1-2 weeks, small at 13 weeks, and no evidence of any effect at 26 weeks. All outcomes were graded LOW quality.

   Jüni P, et al. — Intra-articular corticosteroid for knee osteoarthritis.. Cochrane Database Syst Rev, 2015. DOI: 10.1002/14651858.CD005328.pub3.

3. In a 2-year double-blind RCT of 140 patients with symptomatic knee OA and ultrasound synovitis, 40 mg intra-articular triamcinolone every 12 weeks produced significantly greater cartilage volume loss than saline (index compartment cartilage thickness change -0.21 mm vs -0.10 mm; between-group difference -0.11 mm, 95% CI -0.20 to -0.03) with no significant difference in knee pain.

   McAlindon TE, et al. — Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial.. JAMA, 2017. DOI: 10.1001/jama.2017.5283.

4. A 2025 network meta-analysis restricted to LARGE randomized trials (57 RCTs, 22,795 participants, 18 intra-articular interventions) found treatment effects were larger in the 35 high-risk-of-bias trials than in the 22 low/unclear-risk trials; excluding high-risk trials, triamcinolone had the highest probability of exceeding the minimal important difference at weeks 2 and 6, while hyaluronic acid had no effect on pain (SMD -0.04, 95% CrI -0.19 to 0.11) and higher odds of dropouts due to adverse events (OR 2.01) and serious adverse events (OR 1.86) than placebo.

   Pereira TV, et al. — Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis.. Osteoarthritis Cartilage, 2025. DOI: 10.1016/j.joca.2024.08.014.

5. A clinical review of peripheral joint injections frames them as a treatment for joint-mediated pain (arthritis, tendinopathy, bursitis) that has NOT responded to conservative management, and states plainly that these injections are typically not curative - their objective is to reduce pain enough to allow physical and pharmacologic rehabilitation to work.

   Marcolina A, et al. — Peripheral Joint Injections.. Phys Med Rehabil Clin N Am, 2022. DOI: 10.1016/j.pmr.2022.01.005.

6. A systematic review and meta-analysis of 15 randomized trials (1,023 subjects) assessed intra-articular hyaluronic acid for glenohumeral (shoulder) osteoarthritis pain, evaluating hyaluronic acid plus physical therapy against physical therapy alone among other comparisons.

   Familiari F, et al. — Efficacy of intra-articular injections of hyaluronic acid in patients with glenohumeral joint osteoarthritis: A systematic review and meta-analysis.. J Orthop Res, 2023. DOI: 10.1002/jor.25648.